48,830
edits
Line 619: | Line 619: | ||
*CK7 +ve. | *CK7 +ve. | ||
*CD10 +ve. | *CD10 +ve. | ||
*AMACR +ve. | |||
*Napsin A +ve.<ref name=pmid31361605>{{cite journal |authors=Pors J, Segura S, Cheng A, Ji JX, Tessier-Cloutier B, Cochrane D, Fix DJ, Park K, Gilks B, Hoang L |title=Napsin-A and AMACR are Superior to HNF-1β in Distinguishing Between Mesonephric Carcinomas and Clear Cell Carcinomas of the Gynecologic Tract |journal=Appl Immunohistochem Mol Morphol |volume=28 |issue=8 |pages=593–601 |date=September 2020 |pmid=31361605 |pmc=6987010 |doi=10.1097/PAI.0000000000000801 |url=}}</ref> | |||
*HNF-1beta +ve/-ve. | |||
**Not useful for differentiation from clear cell carcinoma of the gynecologic tract.<ref name=pmid31361605/> | |||
Others:<ref name=Ref_WMSP442>{{Ref WMSP|442}}</ref> | Others:<ref name=Ref_WMSP442>{{Ref WMSP|442}}</ref> |
edits